145 related articles for article (PubMed ID: 12375056)
1. Free radicals in Parkinson's disease.
Koutsilieri E; Scheller C; Grünblatt E; Nara K; Li J; Riederer P
J Neurol; 2002 Sep; 249 Suppl 2():II1-5. PubMed ID: 12375056
[TBL] [Abstract][Full Text] [Related]
2. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
Singh C; Ahmad I; Kumar A
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):19-28. PubMed ID: 17543230
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic neurons reduced to silence by oxidative stress: an early step in the death cascade in Parkinson's disease?
Michel PP; Ruberg M; Hirsch E
Sci STKE; 2006 Apr; 2006(332):pe19. PubMed ID: 16639033
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald A; Lotharius J
Exp Neurol; 2005 Jun; 193(2):279-90. PubMed ID: 15869932
[TBL] [Abstract][Full Text] [Related]
5. Neuronal pathology in Parkinson's disease.
Schulz JB; Falkenburger BH
Cell Tissue Res; 2004 Oct; 318(1):135-47. PubMed ID: 15365812
[TBL] [Abstract][Full Text] [Related]
6. Glial reactions in Parkinson's disease.
McGeer PL; McGeer EG
Mov Disord; 2008 Mar; 23(4):474-83. PubMed ID: 18044695
[TBL] [Abstract][Full Text] [Related]
7. [Free radicals and ailing proteins--the culprits behind Parkinson disease?].
Smith R; Lotharius J; Brundin P
Lakartidningen; 2003 Apr; 100(15):1324-6, 1329-30. PubMed ID: 12739402
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model.
Maetzler W; Berg D; Schalamberidze N; Melms A; Schott K; Mueller JC; Liaw L; Gasser T; Nitsch C
Neurobiol Dis; 2007 Mar; 25(3):473-82. PubMed ID: 17188882
[TBL] [Abstract][Full Text] [Related]
9. [Neuronal death caused by apoptosis in Parkinson disease].
Ruberg M; France-Lanord V; Brugg B; Lambeng N; Michel PP; Anglade P; Hunot S; Damier P; Faucheux B; Hirsch E; Agid Y
Rev Neurol (Paris); 1997 Sep; 153(8-9):499-508. PubMed ID: 9683999
[TBL] [Abstract][Full Text] [Related]
10. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.
Ahlskog JE
Mov Disord; 2005 Mar; 20(3):271-82. PubMed ID: 15580550
[TBL] [Abstract][Full Text] [Related]
11. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
[TBL] [Abstract][Full Text] [Related]
12. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.
McNaught KS; Olanow CW
Neurobiol Aging; 2006 Apr; 27(4):530-45. PubMed ID: 16207501
[TBL] [Abstract][Full Text] [Related]
13. Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
Shukla R; Rajani M; Srivastava N; Barthwal MK; Dikshit M
Int J Neurosci; 2006 Dec; 116(12):1391-402. PubMed ID: 17145675
[TBL] [Abstract][Full Text] [Related]
14. Inflammation in Parkinson's disease: causative or epiphenomenal?
Hald A; Van Beek J; Lotharius J
Subcell Biochem; 2007; 42():249-79. PubMed ID: 17612055
[TBL] [Abstract][Full Text] [Related]
15. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis and Parkinson's disease.
Lev N; Melamed E; Offen D
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):245-50. PubMed ID: 12657363
[TBL] [Abstract][Full Text] [Related]
18. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.
Członkowska A; Kurkowska-Jastrzebska I; Członkowski A; Peter D; Stefano GB
Med Sci Monit; 2002 Aug; 8(8):RA165-77. PubMed ID: 12165754
[TBL] [Abstract][Full Text] [Related]
19. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
[TBL] [Abstract][Full Text] [Related]
20. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains.
Imamura K; Hishikawa N; Ono K; Suzuki H; Sawada M; Nagatsu T; Yoshida M; Hashizume Y
Acta Neuropathol; 2005 Feb; 109(2):141-50. PubMed ID: 15619128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]